Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study.
BACKGROUND: An acquired V617F mutation in JAK2 occurs in most patients with polycythaemia vera, but is seen in only half those with essential thrombocythaemia and idiopathic myelofibrosis. We aimed to assess whether patients with the mutation are biologically distinct from those without, and why th...
Principais autores: | Campbell, P, Scott, L, Buck, G, Wheatley, K, East, C, Marsden, J, Duffy, A, Boyd, E, Bench, A, Scott, M, Vassiliou, G, Milligan, D, Smith, SR, Erber, W, Bareford, D, Wilkins, B, Reilly, J, Harrison, C, Green, A |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2005
|
Registros relacionados
-
JAK2 V617F mutation identifies a biologically distinct subtype of essential thrombocythemia which resembles polycythemia vera.
por: Green, A, et al.
Publicado em: (2005) -
Skin cancer in essential thrombocythaemia and polycythaemia vera patients treated with hydroxycarbamide
por: Abhinav Mathur, et al.
Publicado em: (2022-11-01) -
Cerebral venous sinus thrombosis in JAK2 V617F positive polycythaemia vera presenting as a haemorrhagic stroke
por: N. T. Weerasinghe, et al.
Publicado em: (2021-12-01) -
Real world experience with ropeginterferon alpha-2b (Besremi) in essential thrombocythaemia and polycythaemia vera following exposure to pegylated interferon alfa-2a (Pegasys)
por: Jumoke Okikiolu, et al.
Publicado em: (2023-01-01) -
Polycythaemia vera and central sleep apnoea.
por: Stradling, JR, et al.
Publicado em: (1980)